Bone Density of Newborn Infants to Mothers Treated With Selective Serotonin Reuptake Inhibitor (SSRI)

Sheba Medical Center

Status: Unknown

Conditions: Bone Density

Study type: Observational

Funder types: Other

Identifiers

NCT00818727

SHEBA-09-5435-AM-CTIL

Details and patient eligibility

About

SSRI treatment in adults was found to decrease bone density. The use of SSRI among pregnant women with depression or anxiety is extendent and raising. The effect of bone density of the infants was not yet evaluated.

Enrollment: 40 estimated patients

Sex: All

Ages: 1 to 7 days old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Term newborn infants to mothers treated with SSRI and healthy controls

Exclusion criteria

• Preterms, major congenital malformations.